Actavis is the street name for a prescription cough syrup containing codeine and promethazine, once manufactured by the pharmaceutical company Actavis. It became the most culturally iconic ingredient in “lean,” the recreational drink made by mixing prescription cough syrup with soda. The manufacturer pulled the product from shelves in 2014, but the name lives on in music, online communities, and a thriving black market where sealed bottles command extraordinary prices.
What the Syrup Actually Contains
The product people mean when they say “Actavis” is a liquid formulation combining two drugs: codeine and promethazine. Codeine is an opioid that suppresses cough and relieves mild to moderate pain. Promethazine is an antihistamine with strong sedative and anti-nausea effects. Together, these two drugs are prescribed for temporary relief of cough and upper respiratory symptoms in adults, not for long-term use.
Codeine works as a cough suppressant and a mild pain reliever. Promethazine, meanwhile, relieves allergy symptoms like sneezing and itching but also makes people drowsy, which is part of why the combination appeals to recreational users. Long-term use of the pair is discouraged in clinical settings because both drugs carry risks of tolerance, dependence, and addiction.
How Lean Is Made and Why the Name Stuck
Lean, also called purple drank or sizzurp, is made by pouring a large amount of codeine-promethazine syrup into a cup of soda, usually a lemon-lime variety like Sprite. Some users add hard candy for extra sweetness. The drink gets its purple hue from the dye in the syrup itself. Users sip it slowly over hours, which delivers a sustained, sedating high that fans describe as relaxing and euphoric.
The Actavis brand specifically became the gold standard among lean drinkers. Several other pharmaceutical companies manufactured codeine-promethazine syrup, and those products remain on the market in various forms. But Actavis became synonymous with lean partly through timing. It was widely available during the years when southern hip-hop artists popularized the drink and referenced it by brand name. Rappers promoted its sedating and euphoric effects through music and videos, and the brand identity became inseparable from the drug culture itself.
The Cultural Reach of Purple Drank
Lean first gained mainstream attention as a phenomenon tied to a specific scene: southern rap music, professional athletes, and young Black men in Houston, Texas. Early media coverage and research tended to portray it that way. But the reality turned out to be broader. A systematic review of the medical literature found that the misuse of codeine-promethazine mixtures is not exclusively linked to any single type of user, contradicting the narrower picture painted by American newspapers and social media.
Research outside Houston confirmed this. The first scholarly study of lean use among a general population of young adults, conducted beyond the Houston area, found that use was not limited to Black males. The study reported higher odds of use among several racial and ethnic groups, among males broadly, and among homosexual, bisexual, and transgender college students from urban areas.
This matters because the cultural mystique of Actavis can make lean seem like a niche interest when it is actually a widespread public health concern. The perception that it belongs to one subculture may lead others to underestimate their own risk or the prevalence of use among people around them.
How Codeine Works in the Body, and Why It Hits People Differently
Codeine on its own is actually a weak drug. It has to be converted into morphine inside your liver before it does much of anything. An enzyme called CYP2D6 handles that conversion, and this is where genetics makes things unpredictable. People carry different versions of the gene that codes for this enzyme, and those variations dramatically change how much morphine their body produces from a given dose of codeine.
If you are what pharmacologists call a “poor metabolizer,” your body converts very little codeine into morphine. You would barely feel the effects. If you are an “ultrarapid metabolizer,” your body floods itself with morphine far faster than expected, creating a serious risk of toxicity even at standard prescribed doses. A case report in the New England Journal of Medicine described a patient whose genetic testing revealed three or more functional copies of the CYP2D6 gene, leading to codeine intoxication from what would normally be a routine dose.
Clinical guidelines reflect this danger. The body that oversees pharmacogenetic recommendations has issued specific guidance stating that codeine has little therapeutic effect in poor metabolizers and poses a higher risk of morphine toxicity in ultrarapid metabolizers. These aren’t rare edge cases. Depending on ethnic background, anywhere from a few percent to more than a quarter of the population may fall into one of these extreme metabolizer categories. Someone mixing a large cup of lean has no way of knowing which group they belong to without genetic testing, and recreational users are not getting tested.
What Lean Does to Your Health Over Time
The health consequences of regular lean use go well beyond a hangover. An exploratory study that surveyed lean users on Reddit found striking rates of serious adverse events. About three-quarters of respondents reported experiencing withdrawal symptoms at some point. Roughly two-thirds said they had experienced an overdose. And about a third reported having seizures linked to their lean consumption.
Those numbers are self-reported and come from a community of people who identify as heavy users, so they represent the more extreme end of the spectrum. But they illustrate what happens when the occasional sip turns into a habit. Codeine builds tolerance quickly, meaning users need more and more syrup to achieve the same effect. Higher doses mean more morphine conversion, more respiratory depression, and a narrower margin between getting high and stopping breathing.
Promethazine adds its own layer of danger. A study of adverse drug reaction reports filed with the European Medicines Agency examined over 1,500 cases involving promethazine. Of those, more than 550 were related to abuse, misuse, or dependence. The most common category was outright drug abuse, followed by intentional product misuse. Disturbingly, over half of those abuse-related cases involved fatalities, most recorded as drug toxicity, with opioids being the most commonly reported drugs used alongside promethazine.
Promethazine deepens the sedation that codeine provides, which is the whole point for recreational users but also the mechanism that can kill them. Both drugs suppress activity in the central nervous system. Together, they can slow breathing to dangerous levels, especially in combination with alcohol, benzodiazepines, or other depressants.
Why Actavis Was Discontinued
In 2014, Actavis voluntarily stopped manufacturing its codeine-promethazine syrup. The company stated at the time that the decision was driven by concern over the product’s association with drug abuse and the glamorization of its recreational use. Lean culture had become so visible in mainstream music and social media that the brand name itself was a liability.
The discontinuation did not reduce demand. If anything, it intensified it. Remaining bottles of genuine Actavis-branded syrup became collectors’ items in certain circles, with sealed pints reportedly selling for hundreds or even thousands of dollars. Other manufacturers still produce codeine-promethazine cough syrup under different brand names, and those products contain the same active ingredients in the same concentrations. The pharmacological effect of generic codeine-promethazine syrup is identical to what Actavis sold. But the branding carries cultural weight that the alternatives do not, which is why “Actavis” persists as slang for any codeine-promethazine syrup, regardless of who actually made it.
The Pharmaceutical Company Behind the Name
The corporate history of Actavis is a maze of mergers, acquisitions, and name changes that would confuse even a business journalist. The company that most people associate with the cough syrup was a major generics manufacturer, but it went through an extraordinary series of transformations in a short period.
In 2012, Watson Pharmaceuticals purchased Actavis and adopted the Actavis name. The following year, Actavis acquired Warner Chilcott. In 2014, it absorbed Forest Laboratories. Then, in 2015, Actavis purchased Allergan. Later that same year, the combined company changed its name from Actavis to Allergan. Allergan kept a subsidiary called Actavis Generics, which was then acquired by Teva Pharmaceutical Industries in 2016.
The result is that the “Actavis” name now lives on primarily as a subdivision within Teva, one of the world’s largest generic drug companies. The cough syrup that made the name famous was discontinued before most of these corporate reshufflings were complete. For people outside the pharmaceutical industry, “Actavis” means one thing and one thing only: the syrup. Inside the industry, it refers to a generics operation with a complicated family tree.
Counterfeits and the Aftermarket
The scarcity of genuine Actavis bottles after 2014 created an obvious opening for counterfeit products. Fake Actavis bottles, complete with reproduced labels and packaging, circulate on the black market and through online sellers. Some contain codeine-promethazine syrup sourced from other manufacturers and repackaged. Others contain unknown substances entirely.
This is a serious safety concern beyond the already substantial risks of lean itself. A user buying what they believe is Actavis-branded syrup has no way to verify what is actually in the bottle. Counterfeit products have been found to contain fentanyl, a synthetic opioid that is active in microgram quantities and is responsible for a large share of overdose deaths in the United States. The lethal dose of fentanyl is a tiny fraction of what you would need to overdose on codeine, so even experienced lean users can die from a counterfeit product that looks identical to what they have used before.
The irony is that the cultural cachet of the Actavis brand may make users less cautious. A sealed bottle with the right label creates a false sense of quality control. People who would be wary of an unlabeled substance may trust a convincing counterfeit simply because the branding matches what they have seen in music videos and online forums. The brand loyalty that Actavis cultivated inadvertently, through no marketing effort of its own toward recreational users, now functions as a vulnerability in the illicit market.
What Prescription Codeine-Promethazine Looks Like Today
Codeine-promethazine cough syrup remains a legal prescription medication in the United States, manufactured by several companies other than Actavis. It is classified as a Schedule V controlled substance, the least restrictive controlled substance category, though some states impose stricter controls. Doctors can still prescribe it for severe cough that has not responded to other treatments, but prescribing patterns have shifted. There is growing awareness in the medical community that the combination carries addiction risk that may outweigh its benefits for most cough complaints.
Alternatives exist. Dextromethorphan, the active ingredient in many over-the-counter cough medicines, suppresses cough without opioid activity. Benzonatate is another prescription option that works through a completely different mechanism, numbing the stretch receptors in the lungs. Neither carries the same addiction or respiratory-depression risk as codeine. For most adults with a bad cough, these are safer choices, which is one reason prescribers have become more reluctant to reach for codeine-promethazine unless the situation genuinely calls for it.
The persistence of “Actavis” as a cultural reference point, years after the product vanished from pharmacy shelves, speaks to how powerfully branding and scarcity can shape drug culture. The syrup itself was never pharmacologically unique. Every bottle of generic codeine-promethazine contains the same drugs in the same proportions. What Actavis had was a name that became embedded in music, a purple color that photographed well, and eventually, the mystique of something you could no longer get. That combination proved more durable than the company that made it.